Patents by Inventor Frank Himmelsbach

Frank Himmelsbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6653305
    Abstract: A compound of formula (I) wherein: Ra is a benzyl or 1-phenylethyl group or a phenyl group substituted by the groups R1 and R2, wherein: R1 is a hydrogen, fluorine, chlorine, or bromine atom, or a methyl, trifluoromethyl, cyano, or ethynyl group, and R2 is a hydrogen or fluorine atom; Rb is an R3O—CO—CH2—N—CH2—CH2—OH group optionally substituted at the methylene groups by 1 or 2 methyl or ethyl groups, wherein R3 is a hydrogen atom or a C1-4-alkyl group, a 2-oxomorpholin-4-yl group optionally substituted by 1 or 2 methyl or ethyl groups, or a N-[(1,3-dioxolan-2-yl)methyl]methylamino group; Rc is a hydrogen atom, or a methoxy, ethoxy, 2-methoxyethoxy, 2-ethoxyethoxy, cyclobutyloxy, cyclopentyloxy, cyclohexyloxy, cyclopropylmethoxy, cyclobutylmethoxy, cyclopentylmethoxy, cyclohexylmethoxy, tetrahydrofuran-3-yloxy, tetrahydropyran-3-yloxy, tetrahydropyran-4-yloxy, tetrahydrofuranylmethoxy, or tetrahydropyranylmethoxy group; and n is 1, 2, or 3
    Type: Grant
    Filed: August 15, 2001
    Date of Patent: November 25, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Patent number: 6627634
    Abstract: Bicyclic heterocycles of general formula wherein: Ra to Rd, A to C and X are as defined herein, the tautomers, the stereoisomers and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids or bases, which have valuable pharmacological properties, particularly an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract, and the preparation thereof.
    Type: Grant
    Filed: March 23, 2001
    Date of Patent: September 30, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Publication number: 20030171359
    Abstract: The present invention relates to trisubstituted pyrimidines of formula (I) 1
    Type: Application
    Filed: October 16, 2002
    Publication date: September 11, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Georg Dahmann, Frank Himmelsbach, Bernd Krist, Martin Lenter, Alexander Pautsch, Gisela Schnapp, Martin Steegmaier, Helmut Wittneben, Anthony S. Prokopowicz, Walter Spevak, Andreas Schoops, Steffen Steurer
  • Patent number: 6617329
    Abstract: Compounds of the formula having an inhibitory effect on signal transduction mediated by tyrosine kinases, their use in the treatment of diseases, especially tumoral diseases and diseases of the lungs and air-ways, and the preparation thereof.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: September 9, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Publication number: 20030134838
    Abstract: The present invention relates to trisubstituted pyrimidines of formula 1
    Type: Application
    Filed: October 16, 2002
    Publication date: July 17, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Klaus Bornemann, Hans Briem, Cornelia Dorner-Clossek, Katja Fechteler, Klaus Fuchs, Frank Himmelsbach, Klaus Klinder, Markus Kostka
  • Publication number: 20030130232
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: September 23, 2002
    Publication date: July 10, 2003
    Applicant: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Frank Himmelsbach, Franz Birke, Armin Fugner
  • Publication number: 20030096824
    Abstract: The present invention relates to phenylamidines of general formula 1
    Type: Application
    Filed: October 21, 2002
    Publication date: May 22, 2003
    Inventors: Frank Himmelsbach, Brian Guth
  • Publication number: 20020198205
    Abstract: The present invention relates to substituted xanthines of general formula 1
    Type: Application
    Filed: February 22, 2002
    Publication date: December 26, 2002
    Inventors: Frank Himmelsbach, Michael Mark, Matthias Eckhardt, Elke Langkopf, Roland Maier, Ralf Lotz
  • Patent number: 6489365
    Abstract: Compounds of the formula which is explained more fully in the specification, may be prepared by conventional methods and used therapeutically in conventional galenic preparations.
    Type: Grant
    Filed: January 18, 2000
    Date of Patent: December 3, 2002
    Assignee: Boehringer Ingelheim KG
    Inventors: Ralf Anderskewitz, Kurt Schromm, Ernst-Otto Renth, Frank Himmelsbach, Franz Birke, Armin Fugner
  • Publication number: 20020177601
    Abstract: A compound of formula (I) 1
    Type: Application
    Filed: August 23, 2001
    Publication date: November 28, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Stefan Blech, Birgit Jung, Thomas Metz, Flavio Solca
  • Publication number: 20020173509
    Abstract: A compound of general formula I 1
    Type: Application
    Filed: December 17, 2001
    Publication date: November 21, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Stefan Blech, Birgit Jung, Anke Baum, Flavio Solca
  • Publication number: 20020169180
    Abstract: The present invention relates to bicyclic heterocycles of general formula 1
    Type: Application
    Filed: December 10, 2001
    Publication date: November 14, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Thomas Metz, Flavio Solca, Birgit Jung, Anke Baum
  • Publication number: 20020115675
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: August 22, 2001
    Publication date: August 22, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Publication number: 20020082271
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: August 22, 2001
    Publication date: June 27, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Publication number: 20020082420
    Abstract: A compound of formula (I) 1
    Type: Application
    Filed: August 21, 2001
    Publication date: June 27, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Stefan Blech, Birgit Jung, Thomas Metz
  • Publication number: 20020082270
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: August 22, 2001
    Publication date: June 27, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Publication number: 20020077330
    Abstract: A compound of formula (I) 1
    Type: Application
    Filed: August 15, 2001
    Publication date: June 20, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Patent number: 6403580
    Abstract: Quinazolines of the formula having an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, diseases of the lungs and respiratory tract, and the preparation thereof.
    Type: Grant
    Filed: August 23, 2001
    Date of Patent: June 11, 2002
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavio Solca
  • Publication number: 20020049197
    Abstract: Compounds of the formula 1
    Type: Application
    Filed: August 23, 2001
    Publication date: April 25, 2002
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefan Blech, Flavia Solca
  • Publication number: 20010044435
    Abstract: Bicyclic heterocycles of general formula 1
    Type: Application
    Filed: March 23, 2001
    Publication date: November 22, 2001
    Inventors: Frank Himmelsbach, Elke Langkopf, Birgit Jung, Stefen Blech, Flavio Solca